Moreover, inhibition of CXCR2 dose-dependently decreased CXCL2-triggered migration and proliferation, suggesting that CXCL2 and CXCR2 interactions are operational in murine colon cancer cells. The gene discussed is CXCL2; the disease is malignant colon neoplasm.